Clinical Trial Update: A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating semaglutide administered as a nasal spray for weight management in adults who are overweight or obese; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Semaglutide nasal spray (semaglutide)

Snippet

Sponsor: Shanghai World Leader Pharmaceutical Co., Ltd. | Conditions: Overweight, Obesity | Phase 1 | Status: RECRUITING